Table 3 Association between metabolic status and incident psoriasis according to sex and age.
From: Impact of metabolic status on the incidence of psoriasis: a Korean nationwide cohort study
Group | Incidence ratea | HR (95% CI) | |||
|---|---|---|---|---|---|
Unadjusted | Age-, Sex-adjusted. | MVb-adjusted | |||
Sex | |||||
Male | MHNO | 2.7 | 1 | 1 | 1 |
MUNO | 4.2 | 1.58 (1.49–1.68) | 1.32 (1.24–1.42) | 1.31 (1.22–1.41) | |
MHO | 2.7 | 1.00 (0.92–1.08) | 1.01 (0.93–1.10) | 1.03 (0.95–1.12) | |
MUO | 4.2 | 1.57 (1.47–1.68) | 1.38 (1.29–1.48) | 1.38 (1.28–1.49) | |
Female | MHNO | 2.5 | 1 | 1 | 1 |
MUNO | 3.2 | 1.29 (1.21–1.39) | 1.34 (1.23–1.45) | 1.32 (1.22–1.44) | |
MHO | 2.4 | 0.95 (0.85–1.07 | 0.96 (0.86–1.08) | 0.93 (0.82–1.05) | |
MUO | 3.4 | 1.36 (1.26–1.47) | 1.41 (1.29–1.54) | 1.39 (1.27–1.52) | |
Age (years) | |||||
20–39 | MHNO | 2.5 | 1 | 1 | 1 |
MUNO | 3.4 | 1.39 (1.24–1.55) | 1.40 (1.25–1.57) | 1.34 (1.19–1.52) | |
MHO | 2.5 | 1.02 (0.93–1.12) | 1.04 (0.94–1.14) | 1.03 (0.93–1.14) | |
MUO | 3.3 | 1.31 (1.16–1.47) | 1.33 (1.17–1.51) | 1.34 (1.17–1.52) | |
40–64 | MHNO | 2.7 | 1 | 1 | 1 |
MUNO | 3.7 | 1.36 (1.27–1.44) | 1.26 (1.18–1.345) | 1.25 (1.17–1.34) | |
MHO | 2.6 | 0.96 (0.87–1.06) | 0.93 (0.85–1.03) | 0.94 (0.85–1.04) | |
MUO | 3.8 | 1.41 (1.32–1.51) | 1.30 (1.21–1.39) | 1.28 (1.19–1.38) | |
>65 | MHNO | 2.5 | 1 | 1 | 1 |
MUNO | 4.1 | 1.60 (1.34–1.90) | 1.66 (1.40–1.98) | 1.74 (1.44–2.11) | |
MHO | 2.8 | 1.08 (0.75–1.57) | 1.14 (0.78–1.65) | 1.24 (0.83–1.83) | |
MUO | 4.4 | 1.70 (1.42–2.05) | 1.88 (1.56–2.27) | 1.99 (1.62–2.44) | |
